# Accolade

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/accolade

- Industry: Software
- Headquarters: Seattle, US
- Website: www.accolade.com
- Total disclosed funding: $208M
- Latest round: Series F (Oct 2, 2019)
- Investors on record: 14

## About

Accolade, Inc. is a US-based healthcare technology company that specializes in personalized healthcare solutions, facilitating better access to health benefits and guidance for members.Founded in 2007 in Seattle, US, Accolade, Inc. offers personalized healthcare services. The company has undergone significant changes, including a shift to focus on technology-driven health advocacy. The founders include J Cline, Jake Evans, and Pierre-Etienne BRIET, and the current CEO is Ginika Tor. Accolade has successfully completed 15 deals, with the most recent round being an Add-on raising USD 621.00 mn, contributing to the total amount raised of USD 192.50 mn. The company made its public debut in July 2020, raising USD 220.499 mn through an IPO and followed by an additional USD 192.50 mn in October 2020.Accolade specializes in personalized healthcare solutions designed to create a seamless experience for members seeking access to health benefits and guidance. The company’s core offerings include a personalized Care Advocate service, which pairs each member with a dedicated advocate to navigate healthcare complexities, and a physician-led consultative service for expert medical opinions and optimized treatment plans. Accolade addresses issues such as access to care, patient engagement, and coordination, serving a diverse client base including employers and health plans across various US markets, notably California, Texas, and New York.In 2024, Accolade reported a revenue of USD 414.29 mn and an EBITDA of USD -63.85 mn. The company’s revenue model is based on subscription and partnership structures, with clients paying fees for comprehensive healthcare advocacy services, including plans that provide access to Care Advocates and expert medical consultations for specific healthcare needs.Accolade plans to continue its expansion into new markets, with a focus on increasing its footprint in regions such as the Midwest and Southeast by mid-2025. Recent funding from the ADD-ON round will be utilized to enhance product offerings and invest in technology development. The company is also developing new solutions targeted at improving chronic disease management and plans to introduce these products in the coming year.

## Funding rounds

- Series F, Oct 2, 2019, $20M — Humana Inc, TBA Network
- Series E, Mar 16, 2018, $27M — Madrona Venture Group, Andreessen Horowitz, Cross Creek, Carrick Capital Partners, Madera Invest, McKesson Ventures
- Series E, Jul 26, 2016, $55M — Madrona Venture Group, Andreessen Horowitz
- Series E, Dec 7, 2015, $16M — Comcast Ventures, Accretive, Cressey & Company, Carrick Capital Partners, McKesson Ventures, Interactive Capital Partners
- Series E, Jul 6, 2015, $23M — Comcast Ventures, Accretive, Cressey & Company, Carrick Capital Partners, Pension Plan of Independence Blue Cross, McKesson Ventures, Interactive Capital Partners
- Series D, Dec 12, 2013, $30M — Comcast Ventures, Accretive, Cressey & Company, Carrick Capital Partners
- Series B, Jun 14, 2010, $17M — Comcast Ventures, Oak Hill Capital, Accretive, Cressey & Company, Carrick Capital Partners
- Series A, Feb 1, 2007, $20M — Accretive

## Investors

- Accretive (https://capitalatlas.ai/funds/accretive) — Series A, Series B, Series D, Series E
- Comcast Ventures (https://capitalatlas.ai/funds/comcast-ventures) — Series B, Series D, Series E
- Oak Hill Capital (https://capitalatlas.ai/funds/oak-hill-capital) — Series B
- Cressey & Company (https://capitalatlas.ai/funds/cressey-company) — Series B, Series D, Series E
- Carrick Capital Partners (https://capitalatlas.ai/funds/carrick-capital-partners) — Series B, Series D, Series E
- Pension Plan of Independence Blue Cross — Series E
- McKesson Ventures (https://capitalatlas.ai/funds/mckesson-ventures) — Series E
- Interactive Capital Partners — Series E
- Madrona Venture Group (https://capitalatlas.ai/funds/madrona-venture-group) — Series E
- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Series E
- Cross Creek (https://capitalatlas.ai/funds/cross-creek) — Series E
- Madera Invest — Series E
- Humana Inc — Series F
- TBA Network (https://capitalatlas.ai/funds/tba-network) — Series F